Merkel Cell Carcinoma
Hematology/Oncology Clinics of North America · 2024
DOI: 10.1016/j.hoc.2024.05.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2024. Verfasst von Jennifer Strong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer that is highly radiosensitive and immunogenic. Immunotherapy is the primary treatment of advanced disease, and immune checkpoint inhibitors show promise as neoadjuvant or adjuvant therapy in patients with high-risk resectable MCC. Emerging biomarkers of tumor burden are becoming increasingly important in identifying high-risk patients and in post-treatment surveillance. Further research is needed to determine the optimal duration of anti-PD-(L)1 treatment and second-line options for patients with MCC refractory to immunotherapy. This review covers the characteristics and management of MCC including recent innovations and areas of active investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA.
- Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA. Electronic address: isaac.brownell@nih.gov.
Förderung
- Intramural NIH HHS
- National Institutes of Health
- U.S. Department of Health and Human Services
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Strong, J., Hallaert, P., & Brownell, I. (2024). Merkel Cell Carcinoma. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2024.05.013
Vancouver
Strong J, Hallaert P, Brownell I. Merkel Cell Carcinoma. Hematology/Oncology Clinics of North America. 2024. doi:10.1016/j.hoc.2024.05.013
BibTeX
@article{Strong2024,
author = {Strong, Jennifer and Hallaert, Patrick and Brownell, Isaac},
title = {Merkel Cell Carcinoma},
journal = {Hematology/Oncology Clinics of North America},
year = {2024},
doi = {10.1016/j.hoc.2024.05.013}
}
EUVIMED